Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexpiprazole Adjunctive Therapy in Adults With Major Depressive Disorder With and Without Anxious Distress
DRKS00007103Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of brexpiprazole in major depressive disorder (MDD), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Oct 2014; status: completed.
02
Drugs
brexpiprazole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on DRKS00007103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00007103.